# Clinical risk factors associated with rapid renal function decline after nephrectomy

**Authors:** Ying-Che Huang, Yi-Yang Liu, Hui-Ying Liu, Yin-Lun Chang, Hung-Jen Wang, Yen-Ta Chen, Hao-Lun Luo

PMC · DOI: 10.1186/s12885-026-15541-1 · BMC Cancer · 2026-01-24

## TL;DR

This study identifies diabetes and post-surgery kidney injury as key risk factors for rapid kidney function decline after nephrectomy.

## Contribution

The study introduces a risk stratification model combining diabetes and acute kidney injury to predict post-nephrectomy renal decline.

## Key findings

- 41.8% of patients experienced rapid eGFR decline after nephrectomy.
- Diabetes and postoperative AKI independently predicted renal decline with 1.56 and 1.85 odds ratios respectively.
- Patients with both diabetes and AKI had 1.7-fold higher risk of kidney decline compared to those without either condition.

## Abstract

Nephrectomy inevitably reduces renal mass and increases the risk of chronic kidney disease (CKD). Identifying predictors of early renal decline after surgery is crucial for optimizing long-term outcomes.

We retrospectively analyzed 1723 patients with renal cell carcinoma (RCC) or upper tract urothelial carcinoma (UTUC) from the Taiwan Cancer Database linked with the Chang Gung Research Database (2005–2024). Rapid decline was defined as a decrease in estimated glomerular filtration rate (eGFR) > 3 mL/min/1.73 m² between postoperative month 3 and month 15. Postoperative acute kidney injury (AKI) was defined according to KDIGO criteria. Logistic regression was used to evaluate demographic and clinical predictors. Risk stratification was performed according to diabetes mellitus (DM) and AKI.

Of 1723 patients, 720 (41.8%) experienced rapid decline. Compared with those without decline, affected patients were older, more often female, and had higher rates of hypertension, DM, and hyperlipidemia. Preoperative eGFR < 45 and postoperative AKI were also more common. In multivariate analysis, DM (OR 1.56, 95% CI 1.25–1.94, p < 0.001) and postoperative AKI (OR 1.85, 95% CI 1.43–2.38, p < 0.001) remained independent predictors. Risk stratification showed a stepwise increase in decline: 33.9% without either factor, 47.8% with DM only, 53.3% with AKI only, and 57.8% with both. Patients with both conditions had nearly a 1.7-fold higher risk compared with those without either factor, and Kaplan–Meier analysis confirmed significantly worse outcomes over time (log-rank p < 0.05).

DM and postoperative AKI independently predict early renal deterioration after nephrectomy. Patients with both factors represent a high-risk subgroup requiring intensified surveillance and preventive strategies.

The online version contains supplementary material available at 10.1186/s12885-026-15541-1.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300), renal cell carcinoma (MONDO:0005086), upper tract urothelial carcinoma (MONDO:0020654), diabetes mellitus (MONDO:0005015), hyperlipidemia (MONDO:0021187), acute kidney injury (MONDO:0002492)

## Full-text entities

- **Genes:** TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}
- **Diseases:** ESRD (MESH:D007676), cardiovascular disease (MESH:D002318), hydronephrosis (MESH:D006869), renal or ureteral stones (MESH:D007669), reperfusion injury (MESH:D015427), Urothelial Carcinoma (MESH:D014523), death (MESH:D003643), Hypertension (MESH:D006973), hyperglycemic (MESH:D006944), polycystic kidney disease (MESH:D007690), hyperuricemia (MESH:D033461), RCC (MESH:D002292), impaired renal function (MESH:D007674), Coronary Artery Disease (MESH:D003324), postoperative (MESH:D019106), Cancer (MESH:D009369), tubular injury (MESH:D000230), Diabetes Mellitus (MESH:D003920), nephron (MESH:D007683), CKD (MESH:D051436), hyperglycemia (MESH:D006943), metabolic disturbances (MESH:D024821), hyperlipidemia (MESH:D006949), fibrosis (MESH:D005355), inflammation (MESH:D007249), UTUC (MESH:D012141), disease (MESH:D004194), nephrotic syndrome (MESH:D009404), gout (MESH:D006073), renal decline (MESH:D006030), hypotension (MESH:D007022), ischemia (MESH:D007511), nephron mass loss (MESH:C536030), rapid renal decline (MESH:C538001), AKI (MESH:D058186), function (MESH:D003291)
- **Chemicals:** creatinine (MESH:D003404), AGEs (MESH:D017127)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917967/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917967/full.md

---
Source: https://tomesphere.com/paper/PMC12917967